On March 21, 2024, Calidi Biotherapeutics, Inc. closed the transaction. The transaction included participation from a single investor
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.75 USD | +10.55% |
|
+7.96% | -88.41% |
08/07 | Calidi Biotherapeutics, Inc. Enters into A Certain Loan Agreement with Dennis R. Conklin | CI |
05/07 | Calidi Biotherapeutics to Implement 1-For-10 Reverse Stock Split | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-88.41% | 1.12Cr | |
+20.63% | 13TCr | |
+24.98% | 2.77TCr | |
-20.17% | 2.03TCr | |
-16.73% | 1.68TCr | |
-18.07% | 1.56TCr | |
-47.70% | 1.46TCr | |
+11.92% | 1.48TCr | |
+58.32% | 1.44TCr | |
+149.98% | 1.25TCr |
- Stock Market
- Equities
- CLDI Stock
- News CALI BIOTPAR
- Calidi Biotherapeutics, Inc. announced that it has received $3.5 million in funding